Aliyah Pabani

6PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersEvolutionary computationBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 23, 2026
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

|Apr 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

|Sep 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.

Howard L Li, Soren Charmsaz, Mari Nakazawa

|May 30, 2024
Use of artificial intelligence chatbots in clinical management of immune-related adverse events.

Hannah Burnette, Aliyah Pabani, Mitchell S von Itzstein

|Dec 22, 2023
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study.

Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison

|May 25, 2023
Facts and Hopes: Immunocytokines for Cancer Immunotherapy.

Aliyah Pabani, Justin F Gainor

Pageof 1

Frequent Collaborators

3 joint publications

Julie R Brahmer

2 joint publications

Susan C Scott

2 joint publications

Christine L Hann

2 joint publications

Kristen A Marrone